Cytokine-Mediated Immune Responses in Mycobacterium tuberculosis Infections: Mechanisms, Regulation, and Therapeutic Implications

Ahmad, F., Rani, A., Alam, A., Zarin, S., Pandey, S., Singh, H., Hasnain, S. E., & Ehtesham, N. Z. (2022). Macrophage: A Cell With Many Faces and Functions in Tuberculosis. Frontiers in Immunology, 13, 747799. https://doi.org/10.3389/fimmu.2022.747799

Algood, H. M. S., Lin, P. L., Yankura, D., Jones, A., Chan, J., & Flynn, J. L. (2004). TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection. The Journal of Immunology, 172(11), 6846–6857. https://doi.org/10.4049/jimmunol.172.11.6846

Antonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010). Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. Journal of Clinical Investigation, 120(5), 1674–1682. https://doi.org/10.1172/JCI40817

Beamer, G. L., Flaherty, D. K., Assogba, B. D., Stromberg, P., Gonzalez-Juarrero, M., De Waal Malefyt, R., Vesosky, B., & Turner, J. (2008). Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice. The Journal of Immunology, 181(8), 5545–5550. https://doi.org/10.4049/jimmunol.181.8.5545

Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J. J., Mejias, A., Ramilo, O., Kon, O. M., Pascual, V., Banchereau, J., … O’Garra, A. (2010). An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 466(7309), 973–977. https://doi.org/10.1038/nature09247

Brighenti, S., & Andersson, J. (2012). Local Immune Responses in Human Tuberculosis: Learning From the Site of Infection. The Journal of Infectious Diseases, 205(suppl_2), S316–S324. https://doi.org/10.1093/infdis/jis043

Cambier, C. J., Falkow, S., & Ramakrishnan, L. (2014). Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell, 159(7), 1497–1509. https://doi.org/10.1016/j.cell.2014.11.024

Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., & Katoto, P. D. (2021). Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases, 113, S7–S12. https://doi.org/https://doi.org/10.1016/j.ijid.2021.02.107

Channappanavar, R., & Perlman, S. (2017). Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Seminars in Immunopathology, 39(5), 529–539. https://doi.org/10.1007/s00281-017-0629-x

Charo, I. F., & Ransohoff, R. M. (2006). The Many Roles of Chemokines and Chemokine Receptors in Inflammation. New England Journal of Medicine, 354(6), 610–621. https://doi.org/10.1056/NEJMra052723

Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993). Disseminated tuberculosis in interferon gamma gene-disrupted mice. The Journal of Experimental Medicine, 178(6), 2243–2247. https://doi.org/10.1084/jem.178.6.2243

Correa, P. A., Gomez, L. M., Cadena, J., & Anaya, J.-M. (2005). Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. The Journal of Rheumatology, 32(2), 219.

Couper, K. N., Blount, D. G., & Riley, E. M. (2008). IL-10: The master regulator of immunity to infection. The Journal of Immunology, 180(9), 5771–5777. https://doi.org/https://doi.org/10.4049/jimmunol.180.9.5771

Cruz, A., Khader, S. A., Torrado, E., Fraga, A., Pearl, J. E., Pedrosa, J., Cooper, A. M., & Castro, A. G. (2006). Cutting Edge: IFN-γ Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection. The Journal of Immunology, 177(3), 1416–1420. https://doi.org/10.4049/jimmunol.177.3.1416

Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024). TGF-β signaling in health, disease and therapeutics. Signal Transduction and Targeted Therapy, 9(1), 61. https://doi.org/10.1038/s41392-024-01764-w

Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., & Lessem, E. (2017). The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory Medicine, 5(4), 291–360. https://doi.org/https://doi.org/10.1016/S2213-2600(17)30079-6

Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T. T., Lee, D. M., Fortune, S., Behar, S. M., & Remold, H. G. (2009). Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nature Immunology, 10(8), 899–906. https://doi.org/10.1038/ni.1758

Dorhoi, A., & Kaufmann, S. H. E. (2016). Pathology and immune reactivity: Understanding multidimensionality in pulmonary tuberculosis. Seminars in Immunopathology, 38(2), 153–166. https://doi.org/10.1007/s00281-015-0531-3

Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T. R., Gaasterland, T., Schoolnik, G., & Nathan, C. (2001). Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ and Mycobacterium tuberculosis. The Journal of Experimental Medicine, 194(8), 1123–1140. https://doi.org/10.1084/jem.194.8.1123

Ernst, J. D. (2012). The immunological life cycle of tuberculosis. Nature Reviews Immunology, 12(8), 581–591. https://doi.org/https://doi.org/10.1038/nri3259

Flynn, J. L., & Chan, J. (2022). Immune cell interactions in tuberculosis. Cell, 185(25), 4682–4702. https://doi.org/10.1016/j.cell.2022.10.025

Flynn, J. L., Chan, J., & Lin, P. L. (2011). Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunology, 4(3), 271–278. https://doi.org/https://doi.org/10.1038/mi.2011.14

Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993). An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. The Journal of Experimental Medicine, 178(6), 2249–2254. https://doi.org/10.1084/jem.178.6.2249

Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995). Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity, 2(6), 561–572. https://doi.org/10.1016/1074-7613(95)90001-2

Fremond, C. M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs, M., Ryffel, B., & Quesniaux, V. F. J. (2007). IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection. The Journal of Immunology, 179(2), 1178–1189. https://doi.org/10.4049/jimmunol.179.2.1178

Gideon, H. P., Phuah, J., Myers, A. J., Bryson, B. D., Rodgers, M. A., Coleman, M. T., Maiello, P., Rutledge, T., Marino, S., Fortune, S. M., Kirschner, D. E., Lin, P. L., & Flynn, J. L. (2015). Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization. PLOS Pathogens, 11(1), e1004603. https://doi.org/10.1371/journal.ppat.1004603

Global Tuberculosis Report. (2024). https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024

Gopal, R., Monin, L., Torres, D., Slight, S., Mehra, S., McKenna, K. C., Fallert Junecko, B. A., Reinhart, T. A., Kolls, J., Báez-Saldaña, R., Cruz-Lagunas, A., Rodríguez-Reyna, T. S., Kumar, N. P., Tessier, P., Roth, J., Selman, M., Becerril-Villanueva, E., Baquera-Heredia, J., Cumming, B., … Khader, S. A. (2013). S100A8/A9 Proteins Mediate Neutrophilic Inflammation and Lung Pathology during Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 188(9), 1137–1146. https://doi.org/10.1164/rccm.201304-0803OC

Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014). Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity. Annual Review of Immunology, 32(1), 659–702. https://doi.org/10.1146/annurev-immunol-032713-120145

Guler, R., Ozturk, M., Sabeel, S., Motaung, B., Parihar, S. P., Thienemann, F., & Brombacher, F. (2021). Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis. Frontiers in Immunology, 12, 733853. https://doi.org/10.3389/fimmu.2021.733853

Harris, J., & Keane, J. (2010). How tumour necrosis factor blockers interfere with tuberculosis immunity. Clinical and Experimental Immunology, 161(1), 1–9. https://doi.org/10.1111/j.1365-2249.2010.04146.x

Hmama, Z., Peña‐Díaz, S., Joseph, S., & Av‐Gay, Y. (2015). Immunoevasion and immunosuppression of the macrophage by M ycobacterium tuberculosis . Immunological Reviews, 264(1), 220–232. https://doi.org/10.1111/imr.12268

Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001). Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent. New England Journal of Medicine, 345(15), 1098–1104. https://doi.org/10.1056/NEJMoa011110

Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L., Swain, S. L., Locksley, R. M., Haynes, L., Randall, T. D., & Cooper, A. M. (2007). IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunology, 8(4), 369–377. https://doi.org/10.1038/ni1449

Kleinnijenhuis, J., Oosting, M., Joosten, L. A. B., Netea, M. G., & Van Crevel, R. (2011). Innate Immune Recognition of Mycobacterium tuberculosis. Clinical and Developmental Immunology, 2011, 1–12. https://doi.org/https://doi.org/10.1155/2011/405310

Kuroda, M. J., Sugimoto, C., Cai, Y., Merino, K. M., Mehra, S., Araínga, M., Roy, C. J., Midkiff, C. C., Alvarez, X., Didier, E. S., & Kaushal, D. (2018). High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques. The Journal of Infectious Diseases, 217(12), 1865–1874. https://doi.org/10.1093/infdis/jix625

Lyadova, I. V., & Panteleev, A. V. (2015). Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers. Mediators of Inflammation, 2015(1), 854507. https://doi.org/10.1155/2015/854507

Marino, S., Cilfone, N. A., Mattila, J. T., Linderman, J. J., Flynn, J. L., & Kirschner, D. E. (2015). Macrophage Polarization Drives Granuloma Outcome during Mycobacterium tuberculosis Infection. Infection and Immunity, 83(1), 324–338. https://doi.org/10.1128/IAI.02494-14

Mayer-Barber, K., Barber, D., Shenderov, K., White, S., Wilson, M., Cheever, A., Kugler, D., Sutterwala, F., & Sher, A. (2010). Caspase-1 independent IL-1β Production is critical for MyD88-mediated host resistance to Mycobacterium tuberculosis (42.13). The Journal of Immunology, 184(Supplement_1), 42.13-42.13. https://doi.org/10.4049/jimmunol.184.Supp.42.13

Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A. (2011). Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection. Immunity, 35(6), 1023–1034. https://doi.org/10.1016/j.immuni.2011.12.002

McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019). The IL-17 Family of Cytokines in Health and Disease. Immunity, 50(4), 892–906. https://doi.org/10.1016/j.immuni.2019.03.021

Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., John, L., Van Der Loeff, M. S., Reiss, P., Lynen, L., Janoff, E. N., Gilks, C., & Colebunders, R. (2008). Tuberculosis-associated immune reconstitution inflammatory syndrome: Case definitions for use in resource-limited settings. The Lancet Infectious Diseases, 8(8), 516–523. https://doi.org/10.1016/S1473-3099(08)70184-1

Mishra, B. B., Rathinam, V. A. K., Martens, G. W., Martinot, A. J., Kornfeld, H., Fitzgerald, K. A., & Sassetti, C. M. (2013). Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β. Nature Immunology, 14(1), 52–60. https://doi.org/10.1038/ni.2474

Moore, K. W., De Waal Malefyt, R., Coffman, R. L., & O’Garra, A. (2001). Interleukin-10 and the Interleukin-10 Receptor. Annual Review of Immunology, 19(1), 683–765. https://doi.org/10.1146/annurev.immunol.19.1.683

Mundra, A., Yegiazaryan, A., Karsian, H., Alsaigh, D., Bonavida, V., Frame, M., May, N., Gargaloyan, A., Abnousian, A., & Venketaraman, V. (2023). Pathogenicity of Type I Interferons in Mycobacterium tuberculosis. International Journal of Molecular Sciences, 24(4), 3919. https://doi.org/10.3390/ijms24043919

Nouailles, G., Dorhoi, A., Koch, M., Zerrahn, J., Weiner, J., Faé, K. C., Arrey, F., Kuhlmann, S., Bandermann, S., Loewe, D., Mollenkopf, H.-J., Vogelzang, A., Meyer-Schwesinger, C., Mittrücker, H.-W., McEwen, G., & Kaufmann, S. H. E. (2014). CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. Journal of Clinical Investigation, 124(3), 1268–1282. https://doi.org/10.1172/JCI72030

Opal, S. M., & DePalo, V. A. (2000). Anti-inflammatory cytokines. Chest, 117(4), 1162–1172. https://doi.org/https://doi.org/10.1378/chest.117.4.1162

Ottenhoff, T. H. M., Kumararatne, D., & Casanova, J.-L. (1998). Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunology Today, 19(11), 491–494. https://doi.org/10.1016/S0167-5699(98)01321-8

Pandiarajan, A. N., Kumar, N. P., Selvaraj, N., Ahamed, S. F., Viswanathan, V., Thiruvengadam, K., Hissar, S., Shanmugam, S., Bethunaickan, R., Nott, S., Kornfeld, H., & Babu, S. (2024). Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis. Frontiers in Immunology, 15, 1392256. https://doi.org/10.3389/fimmu.2024.1392256

Parameswaran, N., & Patial, S. (2010). Tumor necrosis factor-α signaling in macrophages. Critical ReviewsTM in Eukaryotic Gene Expression, 20(2). https://doi.org/10.1615/CritRevEukarGeneExpr.v20.i2.10

Philips, J. A., & Ernst, J. D. (2012). Tuberculosis Pathogenesis and Immunity. Annual Review of Pathology: Mechanisms of Disease, 7(1), 353–384. https://doi.org/https://doi.org/10.1146/annurev-pathol-011811-132458

Ramakrishnan, L. (2012). Revisiting the role of the granuloma in tuberculosis. Nature Reviews Immunology, 12(5), 352–366. https://doi.org/10.1038/nri3211

Redford, P. S., Murray, P. J., & O’Garra, A. (2011). The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunology, 4(3), 261–270. https://doi.org/10.1038/mi.2011.7

Roach, D. R., Bean, A. G. D., Demangel, C., France, M. P., Briscoe, H., & Britton, W. J. (2002). TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection. The Journal of Immunology, 168(9), 4620–4627. https://doi.org/10.4049/jimmunol.168.9.4620

Sampath, P., Rajamanickam, A., Thiruvengadam, K., Natarajan, A. P., Hissar, S., Dhanapal, M., Thangavelu, B., Jayabal, L., Ramesh, P. M., Ranganathan, U. D., Babu, S., & Bethunaickan, R. (2023). Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity. Scientific Reports, 13(1), 785. https://doi.org/10.1038/s41598-023-27895-8

Saunders, B. M., Frank, A. A., Orme, I. M., & Cooper, A. M. (2000). Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infection and Immunity, 68(6), 3322–3326. https://doi.org/https://doi.org/10.1128/iai.68.6.3322-3326.2000

Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004). Interferon-γ: An overview of signals, mechanisms and functions. Journal of Leukocyte Biology, 75(2), 163–189. https://doi.org/10.1189/jlb.0603252

Schurz, H., Naranbhai, V., Yates, T. A., Gilchrist, J. J., Parks, T., Dodd, P. J., Möller, M., Hoal, E. G., Morris, A. P., Hill, A. V., & International Tuberculosis Host Genetics Consortium. (2024). Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture. eLife, 13, e84394. https://doi.org/10.7554/eLife.84394

Sendide, K., Deghmane, A.-E., Pechkovsky, D., Av-Gay, Y., Talal, A., & Hmama, Z. (2005). Mycobacterium bovis BCG Attenuates Surface Expression of Mature Class II Molecules through IL-10-Dependent Inhibition of Cathepsin S. The Journal of Immunology, 175(8), 5324–5332. https://doi.org/10.4049/jimmunol.175.8.5324

Seung, K. J., Keshavjee, S., & Rich, M. L. (2015). Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harbor Perspectives in Medicine, 5(9), a017863. https://doi.org/10.1101/cshperspect.a017863

Sia, J. K., Georgieva, M., & Rengarajan, J. (2015). Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells. Journal of Immunology Research, 2015, 1–12. https://doi.org/10.1155/2015/747543

Singhal, A., Jie, L., Kumar, P., Hong, G. S., Leow, M. K.-S., Paleja, B., Tsenova, L., Kurepina, N., Chen, J., Zolezzi, F., Kreiswirth, B., Poidinger, M., Chee, C., Kaplan, G., Wang, Y. T., & De Libero, G. (2014). Metformin as adjunct antituberculosis therapy. Science Translational Medicine, 6(263). https://doi.org/10.1126/scitranslmed.3009885

Stanley, S. A., & Cox, J. S. (2013). Host–Pathogen Interactions During Mycobacterium tuberculosis infections. In J. Pieters & J. D. McKinney (Eds), Pathogenesis of Mycobacterium tuberculosis and its Interaction with the Host Organism (Vol. 374, pp. 211–241). Springer Berlin Heidelberg. https://doi.org/10.1007/82_2013_332

Toossi, Z., Gogate, P., Shiratsuchi, H., Young, T., & Ellner, J. J. (1995). Enhanced production of TGF- beta by blood monocytes from patients with active tuberculosis and presence of TGF- beta in tuberculous granulomatous lung lesions. The Journal of Immunology, 154(1), 465–473. https://doi.org/10.4049/jimmunol.154.1.465

Torrado, E., & Cooper, A. M. (2010). IL-17 and Th17 cells in tuberculosis. Cytokine & Growth Factor Reviews, 21(6), 455–462. https://doi.org/10.1016/j.cytogfr.2010.10.004

Trinchieri, G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Reviews Immunology, 3(2), 133–146. https://doi.org/10.1038/nri1001

Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014). Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1843(11), 2563–2582. https://doi.org/https://doi.org/10.1016/j.bbamcr.2014.05.014

Wallis, R. S., Maeurer, M., Mwaba, P., Chakaya, J., Rustomjee, R., Migliori, G. B., Marais, B., Schito, M., Churchyard, G., Swaminathan, S., Hoelscher, M., & Zumla, A. (2016). Tuberculosis—Advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. The Lancet Infectious Diseases, 16(4), e34–e46. https://doi.org/10.1016/S1473-3099(16)00070-0

Walzl, G., McNerney, R., Du Plessis, N., Bates, M., McHugh, T. D., Chegou, N. N., & Zumla, A. (2018). Tuberculosis: Advances and challenges in development of new diagnostics and biomarkers. The Lancet Infectious Diseases, 18(7), e199–e210. https://doi.org/10.1016/S1473-3099(18)30111-7

Weiss, G., & Schaible, U. E. (2015). Macrophage defense mechanisms against intracellular bacteria. Immunological Reviews, 264(1), 182–203. https://doi.org/10.1111/imr.12266

Zhang, F., Zhang, F., Dong, Y., Li, L., & Pang, Y. (2023). New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review. Infectious Diseases and Therapy, 12(12), 2665–2689. https://doi.org/10.1007/s40121-023-00887-x

Zhuang, L., Yang, L., Li, L., Ye, Z., & Gong, W. (2024). Mycobacterium tuberculosis: Immune response, biomarkers, and therapeutic intervention. MedComm, 5(1), e419. https://doi.org/https://doi.org/10.1002/mco2.419

Zumla, A., Rao, M., Wallis, R. S., Kaufmann, S. H., Rustomjee, R., Mwaba, P., Vilaplana, C., Yeboah-Manu, D., Chakaya, J., & Ippolito, G. (2016). Host-directed therapies for infectious diseases: Current status, recent progress, and future prospects. The Lancet Infectious Diseases, 16(4), e47–e63. https://doi.org/10.1016/S1473-3099(16)00078-5